Nammi Therapeutics begins patient dosing in phase 1 study of QXL138AM for advanced solid tumours and multiple myeloma: Los Angeles Monday, November 11, 2024, 13:00 Hrs [IST] Nammi ...
Health Vectors unveils Smart Health Report to spur future of personal health analytics: Our Bureau, Bengaluru Monday, November 11, 2024, 12:30 Hrs [IST] Health Vectors (HV), a hea ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback